Garg Vipin K — SEC Form 4 filings
SEC reporting owner CIK 1515813. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-29 to 2026-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | Director | 8 | — | — | 37 |
Form 4 filings — Garg Vipin K
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-02 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 26,775 @ $0 · Tax withholding (F): 11,632 @ $5.60 · Grant/award (A): 6,926 @ $3.07 · Option exercise (M): 26,775 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 41,200 @ $0 · Tax withholding (F): 17,898 @ $6.18 · Option exercise (M): 41,200 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 42,050 @ $0 · Tax withholding (F): 17,984 @ $5.50 · Option exercise (M): 42,050 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 26,775 @ $0 · Tax withholding (F): 11,701 @ $7 · Grant/award (A): 4,105 @ $5.18 · Option exercise (M): 16,545 @ $0 · Tax withholding (F): 7,231 @ $6.64 · Option exercise (M): 18,950 @ $0 · +4 more | EDGAR |
| 2025-01-28 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 42,050 @ $0 · Tax withholding (F): 18,157 @ $6.98 · Option exercise (M): 42,050 (derivative) @ $0 · Grant/award (A): 477,500 (derivative) @ $0 · Grant/award (A): 164,800 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 16,545 @ $0 · Tax withholding (F): 7,313 @ $9.88 · Option exercise (M): 18,950 @ $0 · Tax withholding (F): 8,376 @ $9.32 · Option exercise (M): 16,545 (derivative) @ $0 · Option exercise (M): 18,950 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 26,775 @ $0 · Tax withholding (F): 11,697 @ $9.80 · Grant/award (A): 7,889 @ $2.69 · Option exercise (M): 26,775 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 168,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1515813 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →